Epidemiology and diagnostic testing for hemochromatosis and iron overload

International Journal of Laboratory Hematology

Volumn 37, Issue S1, 2015, Pages 25-30

  Adams, P C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Ferritin; Genetic testing; Hemochromatosis; Iron overload

Indexed keywords

FERRITIN; IRON; TRANSFERRIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

CLASSIFICATION ALGORITHM; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; EPIDEMIOLOGICAL DATA; FERRITIN BLOOD LEVEL; GENE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HEMOCHROMATOSIS; HETEROZYGOTE; HFE GENE; HOMOZYGOTE; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER BIOPSY; MASS SCREENING; MUTATIONAL ANALYSIS; NEXT GENERATION SEQUENCING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSFERRIN BLOOD LEVEL; BLOOD; GENETICS; METABOLISM; MUTATION; PROCEDURES;

FERRITINS; GENETIC TESTING; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON OVERLOAD; MASS SCREENING; MEMBRANE PROTEINS; MUTATION; SENSITIVITY AND SPECIFICITY; TRANSFERRIN;

EID: 84929328417     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12347     Document Type: Review

References (23)

1. Lucotte G. Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol Dis 1998;24:433-8.
2. Distante S, Robson KJ, Graham-Campbell J, Maiz-Villena A, Brissot P, Worwood M. The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet 2004;115:269-79.
3. Symonette C, Adams PC. Do all hemochromatosis patients have the same origin? A pilot study of mitochondrial DNA and Y-DNA. Can J Gastroenterol 2011;25:324-6.
4. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-78.
5. Adams PC, Barton JC, McLaren GD, Acton RT, Speechley M, McLaren CE, Reboussin DM, Leiendecker-Foster C, Harris EL, Snively BM, Vogt T, Sholinsky P, Thomson E, Dawkins FW, Gordeuk VR, Eckfeldt JH. Screening for iron overload: lessons from the HEIRS study. Can J Gastroenterol 2009;23:771-4.
6. Adams PC. Hemochromatosis case definition - out of focus? Nat Clin Gastroenterol Hepatol 2006;3:178-9.
7. Adams PC, Reboussin DM, Leiendecker-Foster C, Moses GC, McLaren GD, McLaren CE, Dawkins FW, Kasvosve I, Acton RT, Barton JC, Zaccaro D, Harris EL, Press R, Chang H, Eckfeldt JH. Comparison of the unsaturated iron binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101, 168 participants in the HEIRS study. Clin Chem 2005;51:1048-51.
8. Adams PC, Reboussin DM, Press RD, Barton JC, Acton RT, Moses GC, Leiendecker-Foster C, McLaren GD, Dawkins FW, Gordeuk VR, Lovato L, Eckfeldt JH. Biological variability of transferrin saturation and unsaturated iron binding capacity. Am J Med 2007;120:999.e1-7.
9. Beaton MD, Adams PC. Treatment of hyperferritinemia. Ann Hepatol 2012;11:294-300.
10. Brissot P, Bourel M, Herry D, Verger J-P, Messner M, Beaumont C, Regnouard F, Ferrand B, Simon M. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 1981;80:557-65.
11. McKinnon EJ, Rossi E, Beilby JP, Trinder D, Olynyk JK. Factors that affect serum levels of ferritin in Australian adults and implications for follow-up. Clin Gastroenterol Hepatol 2014;12:101-8.
12. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357-60.
13. St Pierre T, Clark P, Chua-anusorn W, Fleming A, Jeffrey G, Olynyk J, Pootrakul P, Robins E, Lindeman R. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-61.
14. Burke W, Thomson E, Khoury M, McDonnell S, Press N, Adams P, Barton JC, Beutler E, Brittenham G, Buchanan A, Clayton EW, Cogswell ME, Meslin EM, Motulsky AG, Powell LW, Sigal E, Wilfond BS, Collins FS. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998;280:172-8.
15. Shaheen N, Lawrence L, Bacon B, Barton J, Barton N, Galanko J, Martin CF, Burnett CK, Sandler RS. Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end-organ damage. Am J Gastroenterol 2003;98:1175-80.
16. Hall MA, Barton JC, Adams PC, McLaren CE, Reiss JA, Castro O, Ruggiero A, Acton RT, Power TE, Bent TC. Genetic screening for iron overload: no evidence of discrimination at one year. J Fam Pract 2007;56:829-33.
17. Speechley M, Alter D, Guo H, Harrison H, Adams P. Effect of ambiguous hemochromatosis gene test results on physician utilization. Med Care 2012;50:394-8.
18. Harris EL, McLaren CE, Reboussin DM, Gordeuk VR, Barton JC, Acton RT, McLaren GD, Vogt TM, Snively BM, Leiendecker-Foster C, Holup JL, Passmore LV, Eckfeldt JH, Lin E, Adams PC. Serum ferritin and transferrin saturation in Asians and Pacific Islanders. Arch Intern Med 2007;167:722-6.
19. Kotze M, DeVillers J, Bouwens C, Warnich L, Zaahl M, van der Merwe S, Oberkanins C. Molecular diagnosis of hereditary hemochromatosis: application of a newly-developed reverse-hybridization assay in the South African population. Clin Genet 2004;65:317-21.
20. Benyamin B, Esko T, Ried JS, Radhakrishnan A, Vermeulen SH, Traglia M, Gögele M, Anderson D, Broer L, Podmore C, Luan J, Kutalik Z, Sanna S, van der Meer P, Tanaka T, Wang F, Westra HJ, Franke L, Mihailov E, Milani L, Häldin J, Winkelmann J, Meitinger T, Thiery J, Peters A, Waldenberger M, Rendon A, Jolley J, Sambrook J, Kiemeney LA, Sweep FC, Sala CF, Schwienbacher C, Pichler I, Hui J, Demirkan A, Isaacs A, Amin N, Steri M, Waeber G, Verweij N, Powell JE, Nyholt DR, Heath AC, Madden PA, Visscher PM, Wright MJ, Montgomery GW, Martin NG, Hernandez D, Bandinelli S, van der Harst P, Uda M, Vollenweider P, Scott RA, Langenberg C, Wareham NJ, InterAct Consortium, van Duijn C, Beilby J, Pramstaller PP, Hicks AA, Ouwehand WH, Oexle K, Gieger C, Metspalu A, Camaschella C, Toniolo D, Swinkels DW, Whitfield JB. Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. Nat Commun 2014;5:4926.
21. Barton JC, Lafreniere SA, Leiendecker-Foster C, Li H, Acton RT, Press RD, Eckfeldt JH. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants. Am J Hematol 2009;84:710-4.
22. McLaren C, Emond M, Subramanian N, Phatak P, Barton JC, Adams PC, Goh JB, McDonald CJ, Powell LW, Gurrin LC, Allen KJ, Nickerson DA, Louie T, Ramm GA, Anderson GJ, McLaren GD. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe Iron overload. Hepatology 2015. doi: 10.1002/hep.27711. [Epub ahead of print]
23. Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R; International Parkinson's Disease Genomics Consortium (IPDGC); Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI); 23andMe; GenePD; NeuroGenetics Research Consortium (NGRC); Hussman Institute of Human Genomics (HIHG); Ashkenazi Jewish Dataset Investigator; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE); North American Brain Expression Consortium (NABEC); United Kingdom Brain Expression Consortium (UKBEC); Greek Parkinson's Disease Consortium; Alzheimer Genetic Analysis Group, Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 2014;46:989-93.